Ron T Varghese

Dr. Ron T Varghese

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2017 in Diabetologia
Verified
Journal Article
Closed access
PDF file
ASAnu Sharma
Anu Sharma
MLMarcello C. Laurenti
Marcello C. Laurenti
Chiara Dalla ManChiara Dalla Man
Chiara Dalla Man
RVRon T Varghese
Ron T Varghese
CCClaudio Cobelli
Claudio Cobelli
AVAdrian Vella
Adrian Vella

2 November 2015 in Diabetes
Verified
Journal Article
Open access
PDF file
MSMeera Shah
Meera Shah
RVRon T Varghese
Ron T Varghese
JMJohn M. Miles
John M. Miles
FPFrancesca Piccinini
Francesca Piccinini
Chiara Dalla ManChiara Dalla Man
Chiara Dalla Man
AVAdrian Vella
Adrian Vella
The diabetes-associated allele in TCF7L2 increases the rate of conversion to diabetes; however, the mechanism by which this occurs remains elusive. We hypothesized that the diabetes-associated allele in this locus (rs7903146) impairs insulin secretion and that this defect would be exacerbated by acute free fatty acid (FFA)–induced insulin resistance. We studied 120 individuals of whom one-half were homozygous for the diabetes-associated allele TT at rs7903146 and one-half were homozygous for the protective allele CC. After a screening examination during which glucose tolerance status was determined, subjects were studied on two occasions in random order while undergoing an oral challenge. During one study day, FFA was elevated by infusion of Intralipid plus heparin. On the other study day, subjects received the same amount of glycerol as present in the Intralipid infusion. β-Cell responsivity indices were estimated with the oral C-peptide minimal model. We report that β-cell responsivity was slightly impaired in the TT genotype group. Moreover, the hyperbolic relationship between insulin secretion and β-cell responsivity differed significantly between genotypes. Subjects also exhibited impaired suppression of glucagon after an oral challenge. These data imply that a genetic variant harbored within the TCF7L2 locus impairs glucose tolerance through effects on glucagon as well as on insulin secretion.

18 November 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
MBMonica Bodenstab
Monica Bodenstab
RVRon T Varghese
Ron T Varghese
Gianluca IacobellisGianluca Iacobellis
Gianluca Iacobellis
Epicardial adipose tissue is a unique visceral adipose tissue depot that plays a crucial role in myocardial metabolism. Epicardial adipose tissue is a major source of energy and free fatty acids for the adjacent myocardium. However, under pathological conditions, epicardial fat can affect the heart through the excessive and abnormal influx of lipids. The cardio-lipotoxicity of the epicardial adipose tissue is complex and involves different pathways, such as increased inflammation, the infiltration of lipid intermediates such as diacylglycerol and ceramides, mitochondrial dysfunction, and oxidative stress, ultimately leading to cardiomyocyte dysfunction and coronary artery ischemia. These changes can contribute to the pathogenesis of various cardio-metabolic diseases including atrial fibrillation, coronary artery disease, heart failure, and obstructive sleep apnea. Hence, the role of the cardio-lipotoxicity of epicardial fat and its clinical implications are discussed in this review.

6 November 2017 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
ASAnu Sharma
Anu Sharma
RVRon T Varghese
Ron T Varghese
MSMeera Shah
Meera Shah
Chiara Dalla ManChiara Dalla Man
Chiara Dalla Man
CCClaudio Cobelli
Claudio Cobelli
AVAdrian Vella
Adrian Vella
Context Abnormal glucagon concentrations contribute to hyperglycemia but the mechanism(s) of α-cell dysfunction in prediabetes are unclear. Objective We sought to determine the relative contributions of insulin secretion and action to α-cell dysfunction in non-diabetic subjects across the spectrum of glucose tolerance. Design This was a cross-sectional study. A subset of subjects (n = 120) was studied in the presence and absence of free fatty acid (FFA) elevation, achieved by infusion of intralipid + heparin, to cause insulin resistance. Setting An Inpatient Clinical Research Unit at an academic medical center. Patients or Other Participants A total of 310 non-diabetic subjects participated in this study. Intervention(s) Subjects underwent a 7-sample oral glucose tolerance test. Subsequently, 120 subjects were studied on two occasions. On one day infusion of intralipid + heparin raised FFA. On the other day subjects received glycerol (GLY) as a control. Main Outcome Measure(s) We examined the relationship of glucagon concentration with indices of insulin action after adjusting for the effects of age, sex and weight. Subsequently, we sought to determine whether an acute decrease in insulin action, produced by FFA elevation, altered glucagon concentrations in non-diabetic subjects. Results Fasting glucagon concentrations correlated positively with fasting insulin and C-peptide concentrations and inversely with insulin action (Si ). Fasting glucagon was not associated with any index of β-cell function in response to an oral challenge. As expected, FFA elevation decreased insulin action and also raised glucagon concentrations. Conclusions In non-diabetic subjects glucagon secretion is altered by changes in insulin action.

28 January 2016 in Diabetes
Verified
Journal Article
Open access
PDF file
RVRon T Varghese
Ron T Varghese
Ivan ViegasIvan Viegas
Ivan Viegas
CBCristina Barosa
Cristina Barosa
CMCatia Marques
Catia Marques
MSMeera Shah
Meera Shah
AVAdrian Vella
Adrian Vella
Common genetic variation in TCF7L2 is associated with type 2 diabetes. However the mechanism by which this occurs remains elusive. In addition to affecting insulin secretion, genetic variation at the TCF7L2 locus may alter insulin action or directly modify hepatic glucose metabolism. We sought to determine whether the diabetes-associated variant in this locus (T allele of rs7903146) increases fasting endogenous glucose production (EGP), impairs insulin-induced suppression of EGP and insulin-stimulated glucose disappearance. To address this, we studied individuals who were either homozygous for the diabetes-associated allele (TT) at rs7903146 or homozygous for the protective allele (CC). Subjects were matched for other anthropometric characteristics and were studied using a euglycemic clamp. EGP and glucose uptake was measured using the tracer dilution technique and the relative contribution of gluconeogenesis to EGP quantitated using deuterated water corrected for transaldolase exchange. We report that the diabetes-associated variation in TCF7L2 did not associate with fasting EGP, insulin-induced suppression of EGP and insulin-induced stimulation of glucose uptake. There was no association with the contribution of gluconeogenesis and glycogenolysis to EGP. These data indicate that genetic variation at TCF7L2 does not predispose to type 2 diabetes by altering either hepatic or extra-hepatic insulin action.

9 April 2020 in JCI Insight
Verified
Journal Article
Open access
PDF file
MLMarcello Laurenti
Marcello Laurenti
Chiara Dalla ManChiara Dalla Man
Chiara Dalla Man
RVRon T Varghese
Ron T Varghese
JAJames C. Andrews
James C. Andrews
RRRobert A. Rizza
Robert A. Rizza
AVAdrian Vella
Adrian Vella
BACKGROUND: Metabolic disorders such as type 2 diabetes have been associated with a decrease in insulin pulse frequency and amplitude. We hypothesized that the T allele at rs7903146 in TCF7L2, previously associated with β cell dysfunction, would be associated with changes in these insulin pulse characteristics. METHODS: Twenty-nine nondiabetic subjects (age 46 ± 2, BMI 28 ± 1 kg/m 2 ) participated in this study. Of these, 16 were homozygous for the C allele at rs7903146 and 13 were homozygous for the T allele. Deconvolution of peripheral C-peptide concentrations allowed the reconstruction of portal insulin secretion over time. These data were used for subsequent analyses. Pulse orderliness was assessed by approximate entropy (ApEn), and the dispersion of insulin pulses was measured by a frequency dispersion index (FDI) after a Fast Fourier Transform (FFT) of individual insulin secretion rates. RESULTS: During fasting conditions, the CC genotype group exhibited decreased pulse disorderliness compared with the TT genotype group (1.10 ± 0.03 vs. 1.19 ± 0.04, P = 0.03). FDI decreased in response to hyperglycemia in the CC genotype group, perhaps reflecting less entrainment of insulin secretion during fasting. CONCLUSION: Diabetes-associated variation in TCF7L2 is associated with decreased orderliness and pulse dispersion, unchanged by hyperglycemia. Quantification of ApEn and FDI could represent novel markers of β cell health. FUNDING: This work was funded by US NIH (DK78646, DK116231), University of Padova research grant CPDA145405, and Mayo Clinic General Clinical Research Center (UL1 TR000135).